Tag: 5-HT2A antagonists

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to 5-HT2A antagonists

Minerva Neurosciences (NASDAQ:NERV) Now Covered by Analysts at StockNews.com

Added to Collection on: 2024-11-10 07:24:41

Tags for this article:

Finance
Money
Economy
5-HT2A antagonists
Antipsychotics
Ketones
Organofluorides
Piperidines
Roluperidone
Minerva
Securities research
Financial analyst
Minerva Neurosciences Inc

Click the tags to see associated articles and topics

View Article Details
StockNews.com Begins Coverage on Minerva Neurosciences (NASDAQ:NERV)

Added to Collection on: 2025-01-05 08:14:21

Tags for this article:

Financial markets
Economy
Finance
Stock market
5-HT2A antagonists
Antipsychotics
Organofluorides
Roluperidone
Minerva
Short
Stock
Minerva Neurosciences Inc

Click the tags to see associated articles and topics

View Article Details
Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated at StockNews.com

Added to Collection on: 2024-07-21 05:39:22

Tags for this article:

Finance
Economy
Money
5-HT2A antagonists
Economy of South Korea
Kakao
Minerva
Roluperidone
Hedge fund
Short
Stock
Minerva Neurosciences Inc

Click the tags to see associated articles and topics

View Article Details
Many Adults and Children With Insomnia Use Trazodone in the United States

Added to Collection on: 2022-09-21 03:58:22

Tags for this article:

Psychoactive drugs
RTT
5-HT2A antagonists
Anxiolytics
Trazodone
Ureas
Insomnia
angelini
Cohort study
IBM
United States
Angelini Pharma

Click the tags to see associated articles and topics

View Article Details
New patent expiration for Otsuka drug ABILIFY MYCITE KIT - Biotechblog

Added to Collection on: 2022-09-25 10:35:41

Tags for this article:

Psychoactive drugs
Drugs
Neurochemistry
Antidepressants
5-HT2A antagonists
Otsuka Pharmaceutical
RTT
Aripiprazole
Bristol-Myers Squibb
Patent
Abilify

Click the tags to see associated articles and topics

View Article Details
Schizophrenia Drugs Market Report (2022 to 2030) - H. - GlobeNewswire

Added to Collection on: 2022-10-12 22:23:27

Tags for this article:

Psychiatry
Psychoactive drugs
Psychopathology
RTT
Neuroscience
Mood stabilizers
5-HT2A antagonists
Antidepressants
Atypical antipsychotic
Antipsychotic
Schizophrenia
Aripiprazole

Click the tags to see associated articles and topics

View Article Details
What is the new drug for schizophrenia. 2005 NIMH researchers report

Added to Collection on: 2022-10-23 14:51:59

Tags for this article:

Psychoactive drugs
Serotonin antagonists
Chemical compounds
Atypical antipsychotics
RTT
Mood stabilizers
Antidepressants
5-HT2A antagonists
Antipsychotic
Schizophrenia
Olanzapine
Iloperidone
Dopamine

Click the tags to see associated articles and topics

View Article Details
FY2022 EPS Estimates for Minerva Neurosciences, Inc. (NASDAQ:NERV) Reduced by HC ...

Added to Collection on: 2022-11-14 07:59:11

Tags for this article:

Financial ratios
Chemical compounds
Corporate finance
Fundamental analysis
5-HT2A antagonists
Economy
Earnings per share
Minerva
Roluperidone
Price?earnings ratio
Landforms
Minerva Neurosciences Inc

Click the tags to see associated articles and topics

View Article Details
BioXcel Therapeutics Announces First Patients Dosed in SERENITY III Phase 3 Trial for ...

Added to Collection on: 2022-12-02 17:37:33

Tags for this article:

Clinical research
Design of experiments
Clinical trials
Psychoactive drugs
Serenity
Placebo-controlled study
Medical research
Chemical compounds
5-HT2A antagonists
Antidepressants
Brexpiprazole
SERENITY III
United States
BioXcel Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Schizophrenia Drugs Market SWOT Analysis by Leading - openPR.com

Added to Collection on: 2024-09-25 20:47:59

Tags for this article:

Atypical antipsychotics
H1 receptor antagonists
Mood stabilizers
5-HT2A antagonists
Ethers
Antipsychotic
Schizophrenia
Market share
Quetiapine
Eli Lilly and Company
Pharmaceutical industry in China
Risperidone

Click the tags to see associated articles and topics

View Article Details